信必可都保80ug4.5ug吸入聯(lián)合無水緩釋茶堿片口服與信必可都保160ug4.5ug吸入治療成人支氣管哮喘療效對比

1、廣州醫(yī)學(xué)院碩士學(xué)位論文信必可都保80ug/4.5ug吸入聯(lián)合無水緩釋茶堿片口服與信必可都保160ug/4.5ug吸入治療成人支氣管哮喘療效對比姓名：陳瑞芳申請學(xué)位級別：碩士專業(yè)：內(nèi)科學(xué)指導(dǎo)教師：張挪富2011-06信必可都保 80ug/4.5ug 吸入聯(lián)合無水緩釋茶堿片口服與信必可都保 160ug/4.5ug 吸入治療成人支氣管哮喘療效對比 3 The Comparison of Effect of Symbicort Tu

2、rbuhaler80ug/4.5ug combined with Anhydrous Theophylline Sustained Tablets and Symbicort Turbuhaler160ug/4.5ug in the Treatment of Patients with Moderate Bronchial Asthma Postgraduate: Ruifang Chen Specia

3、lity: Internal Medicine Tutor: Prof. Zhang Nuofu ABSTRACT Objective: To observe the efficacy ，safety and pharmacoeconomics of inhaled Symbicort turbuhaler (budesonide and formoterol fumarate powder)

4、80ug/4.5ug combined with oral Anhydrous Theophylline Sustained tablets and inhaled Symbicort Turbuhaler 160ug/4.5ug in the treatment of patients with moderate bronchial asthma and compare the curati

5、ve effect. Methods : 60 patients with moderate bronchial asthma were randomly divided into A and B groups .30 cases in group A were treated with inhaled Symbicort turbuhaler 80ug/4.5ug, one inh

6、alations，twice a day combined with oral sustained- release theophylline ,200 mg per 12 hour. 30cases in group B were treated with inhaled Symbicort turbuhaler 160ug/4.5ug, one inhalations，twice a

7、 day. Both groups were received a treatment course of 12 weeks. Furthermore，Symbicort turbuhaler could be used when symptoms were poorly controlled. The change of clinical symptoms 、FEVl、FEVl％and

8、adverse events were observed before and after treatment. Results: Both groups got remarkable improvement in clinic basic control rate, ACT scores and lung function(FEVl and FEVl％) and they show